AR019728A1 - Metodo para reducir los efectos perjudiciales de la terapia con radiacion sobre la piel y la mucosa animal - Google Patents

Metodo para reducir los efectos perjudiciales de la terapia con radiacion sobre la piel y la mucosa animal

Info

Publication number
AR019728A1
AR019728A1 ARP990103126A ARP990103126A AR019728A1 AR 019728 A1 AR019728 A1 AR 019728A1 AR P990103126 A ARP990103126 A AR P990103126A AR P990103126 A ARP990103126 A AR P990103126A AR 019728 A1 AR019728 A1 AR 019728A1
Authority
AR
Argentina
Prior art keywords
skin
reducing
radiation therapy
harmful effects
animal mucosa
Prior art date
Application number
ARP990103126A
Other languages
English (en)
Original Assignee
Colgate Palmolive Co
Univ Colorado State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co, Univ Colorado State Res Found filed Critical Colgate Palmolive Co
Publication of AR019728A1 publication Critical patent/AR019728A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se trata de un método para atemperar los danos producidos en la piel y mucosas de animales con cáncer en tratamiento radioterapéuticos mediante laadministracion de composiciones alimentarias nutritivamente balanceados que contiene ácidos grasos omega-6 poliinsaturados suplementada con ácidos grasos omega-3 poliinsaturados y arginina.
ARP990103126A 1998-06-29 1999-06-29 Metodo para reducir los efectos perjudiciales de la terapia con radiacion sobre la piel y la mucosa animal AR019728A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (1)

Publication Number Publication Date
AR019728A1 true AR019728A1 (es) 2002-03-13

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103126A AR019728A1 (es) 1998-06-29 1999-06-29 Metodo para reducir los efectos perjudiciales de la terapia con radiacion sobre la piel y la mucosa animal

Country Status (17)

Country Link
US (1) US6015798A (es)
EP (1) EP1091734B1 (es)
JP (2) JP4860814B2 (es)
AR (1) AR019728A1 (es)
AT (1) ATE249821T1 (es)
AU (1) AU761266B2 (es)
BR (1) BR9911663A (es)
CA (1) CA2336628C (es)
DE (1) DE69911409T2 (es)
DK (1) DK1091734T3 (es)
ES (1) ES2207951T3 (es)
MX (1) MXPA01000152A (es)
NO (1) NO329910B1 (es)
NZ (1) NZ508766A (es)
TR (1) TR200100457T2 (es)
WO (1) WO2000000189A1 (es)
ZA (1) ZA200007650B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
EP1213971B1 (en) * 1999-09-09 2011-06-15 Societe Des Produits Nestle S.A. Improving condition of elderly pets
AU5743501A (en) * 2000-05-01 2001-11-12 Iams Company Pet food composition for reducing inflammatory response in cats
US7084175B2 (en) 2000-06-01 2006-08-01 United Feeds Animal food and method
ATE492166T1 (de) * 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
EP1589828A1 (en) * 2002-12-23 2005-11-02 Mars Uk Limited Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
MXPA05013757A (es) * 2003-08-11 2006-03-08 Hills Pet Nutrition Inc Acidos grasos omega-3 para el tratamiento de osteoartritis canina.
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
WO2005018632A1 (en) * 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
CN1905807B (zh) * 2003-11-25 2011-08-24 弗吉尼亚科技知识产权有限公司 用于动物消费的组合物和降低map激酶活性的方法
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
JP2008526214A (ja) 2004-12-30 2008-07-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 発育期の動物の生活の質を高めるための方法
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
EP2214481B1 (en) 2007-10-15 2019-05-01 United Animal Health, Inc. Method for increasing performance of offspring
WO2009070589A1 (en) * 2007-11-30 2009-06-04 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
MX367038B (es) * 2012-11-15 2019-08-02 Hills Pet Nutrition Inc Control de bola de pelo a traves de limitacion mineral en la dieta.
US11065220B2 (en) 2017-02-13 2021-07-20 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
KR20210108942A (ko) * 2018-10-01 2021-09-03 윈터뮤트 바이오메디컬 인코포레이티드 치료 조성물
EP4022090A1 (en) * 2019-12-19 2022-07-06 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions
AU2019479288B2 (en) 2019-12-19 2024-04-18 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
EP0367724B1 (en) * 1988-10-31 1993-02-10 Sandoz Nutrition Ltd. Improvements in or relating to organic compounds
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma

Also Published As

Publication number Publication date
EP1091734A1 (en) 2001-04-18
DE69911409T2 (de) 2004-07-08
US6015798A (en) 2000-01-18
ZA200007650B (en) 2002-08-28
DK1091734T3 (da) 2004-01-26
NO20006575L (no) 2001-02-28
AU761266B2 (en) 2003-05-29
ES2207951T3 (es) 2004-06-01
MXPA01000152A (es) 2002-10-17
JP2009035533A (ja) 2009-02-19
NO329910B1 (no) 2011-01-24
NZ508766A (en) 2003-05-30
JP5704791B2 (ja) 2015-04-22
CA2336628A1 (en) 2000-01-06
NO20006575D0 (no) 2000-12-21
CA2336628C (en) 2009-03-24
WO2000000189A1 (en) 2000-01-06
JP4860814B2 (ja) 2012-01-25
EP1091734B1 (en) 2003-09-17
AU4716799A (en) 2000-01-17
DE69911409D1 (de) 2003-10-23
BR9911663A (pt) 2005-12-20
TR200100457T2 (tr) 2001-08-21
ATE249821T1 (de) 2003-10-15
JP2002519320A (ja) 2002-07-02

Similar Documents

Publication Publication Date Title
AR019728A1 (es) Metodo para reducir los efectos perjudiciales de la terapia con radiacion sobre la piel y la mucosa animal
AR029615A1 (es) Una formulacion farmaceutica para la administracion oral
ES2168334T3 (es) Composicion para el tratamiento de la piel.
SE8803141D0 (sv) Neringsmedel for menniskor och djur
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
MX9100229A (es) Composiciones alimenticias y farmaceuticas que contienen acidos grasos monoinsaturados de cadena corta,y metodos de uso
BR0214155A (pt) Almofada protetora para seios contendo um ingrediente que proporciona benefìcios para a pele
ES2176343T3 (es) Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos.
FI863976A0 (fi) Terapeutisk komposition.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
CO2021011652A2 (es) Ésteres de ácido graso como agentes anti-malassezia
PT1023034E (pt) Formulacoes cosmeticas para prevencao e tratamento da queda de cabelo
ES2194157T3 (es) Composiciones para el cuidado de la piel que contienen un retinoide.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
FI913517A0 (fi) Salicylsyrahaltigt aemne mot fjaellande hudsjukdomar.
SE8304331L (sv) Lekemedel med analgetisk verkan
ATE164766T1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
AR021830A1 (es) Utilizacion de acido docosahexaenoico y acido araquidonico para mejorar el crecimiento de bebes anteriores a termino
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick
RU2071681C1 (ru) Состав для жирования кож
RU94021279A (ru) Препарат для лечения и профилактики мастита крупного рогатого скота
PE20000032A1 (es) El metodo de estabilizacion de las grasas, aceites, composiciones insaturadas y de los productos que ellos contienen, y composicion para la ejecucion del metodo
ES2138571B1 (es) Procedimiento cosmetico para el tratamiento de la piel.

Legal Events

Date Code Title Description
FC Refusal